Stephanie L Siehr1, Katsuhide Maeda2, Andrew A Connolly3, Theresa A Tacy4, V Mohan Reddy2, Frank L Hanley2, Stanton B Perry4, Gail E Wright4. 1. Division of Pediatric Cardiology, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California. Electronic address: ssiehr@stanford.edu. 2. Division of Pediatric Cardiac Surgery, Department of Cardiothoracic Surgery, Stanford University School of Medicine, Palo Alto, California. 3. Department of Pathology, Stanford University School of Medicine, Palo Alto, California. 4. Division of Pediatric Cardiology, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California.
Abstract
BACKGROUND: There are conflicting reports regarding the importance of mitral stenosis and aortic atresia as a risk factor for Norwood mortality. This study reviews outcomes of this anatomic subgroup at our institution and examines the utility of preoperative cardiac catheterization and its correlation with clinical outcomes and pathology findings. METHODS: This is a single-center, retrospective review of hypoplastic left heart syndrome patients who underwent modified Norwood operation between October 2005 and May 2013. RESULTS: Fourteen of 74 hypoplastic left heart syndrome patients (19%) had mitral stenosis and aortic atresia. Operative mortality for MS/AA was 29% versus 7% for all other hypoplastic left heart syndrome anatomic subgroups (p = 0.04). Although only 19% of the entire cohort, the mitral stenosis and aortic atresia subgroup constituted 50% of the total operative mortality and the only interstage deaths. Autopsies support myocardial ischemia as the mechanism of death. Although preoperative angiography defined the presence of ventriculo-coronary connections, it did not clearly risk stratify patients in regard to operative mortality. CONCLUSIONS: Mitral stenosis and aortic atresia is a risk factor for perioperative myocardial ischemia and mortality. Further exploration of myocardial reserve is warranted.
BACKGROUND: There are conflicting reports regarding the importance of mitral stenosis and aortic atresia as a risk factor for Norwood mortality. This study reviews outcomes of this anatomic subgroup at our institution and examines the utility of preoperative cardiac catheterization and its correlation with clinical outcomes and pathology findings. METHODS: This is a single-center, retrospective review of hypoplastic left heart syndromepatients who underwent modified Norwood operation between October 2005 and May 2013. RESULTS: Fourteen of 74 hypoplastic left heart syndromepatients (19%) had mitral stenosis and aortic atresia. Operative mortality for MS/AA was 29% versus 7% for all other hypoplastic left heart syndrome anatomic subgroups (p = 0.04). Although only 19% of the entire cohort, the mitral stenosis and aortic atresia subgroup constituted 50% of the total operative mortality and the only interstage deaths. Autopsies support myocardial ischemia as the mechanism of death. Although preoperative angiography defined the presence of ventriculo-coronary connections, it did not clearly risk stratify patients in regard to operative mortality. CONCLUSIONS:Mitral stenosis and aortic atresia is a risk factor for perioperative myocardial ischemia and mortality. Further exploration of myocardial reserve is warranted.
Authors: Alan P Wang; Angela M Kelle; Meredith Hyun; Chelsea L Reece; Phillip M Young; Patrick W O'Leary; M Yasir Qureshi Journal: Pediatr Cardiol Date: 2020-10-26 Impact factor: 1.655
Authors: A Crucean; A Alqahtani; D J Barron; W J Brawn; R V Richardson; J O'Sullivan; R H Anderson; D J Henderson; B Chaudhry Journal: Orphanet J Rare Dis Date: 2017-08-10 Impact factor: 4.123
Authors: Katrin Fricke; Mats Mellander; Katarina Hanséus; Phan-Kiet Tran; Mats Synnergren; Jens Johansson Ramgren; Annika Rydberg; Jan Sunnegårdh; Magnus Dalén; Gunnar Sjöberg; Constance G Weismann; Petru Liuba Journal: J Am Heart Assoc Date: 2022-03-29 Impact factor: 6.106
Authors: Rodrigo Freire Bezerra; Juliana Torres Pacheco; Sônia Meiken Franchi; Rosangela Belbuche Fittaroni; José Francisco Baumgratz; Rodrigo Moreira Castro; Luciana da Fonseca da Silva; José Pedro da Silva Journal: Arq Bras Cardiol Date: 2022-08 Impact factor: 2.667